Developmental differences in megakaryocyte size in infants and children

American Journal of Clinical Pathology

Volumn 138, Issue 1, 2012, Pages 140-145

  Fuchs, Deborah A ^a   McGinn, Sarah G ^a   Cantu, Carlos L ^a   Klein, Robert R ^a   Sola Visner, Martha C ^b   Rimsza, Lisa M ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Bone marrow; CD61; Megakaryocyte; Thrombocytopenia

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BONE MARROW BIOPSY; BONE MARROW EXAMINATION; CELL COUNT; CELL SIZE; CHILD; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INFANT; MALE; MEGAKARYOCYTE; NEWBORN; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CELL COUNT; CELL SIZE; CHILD; CHILD DEVELOPMENT; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MEGAKARYOCYTES; MIDDLE AGED;

EID: 84864203493     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCP4EMTJYA0VGYE     Document Type: Article

References (19)

1. de Alarcon PA, Graeve JL. Analysis of megakaryocyte ploidy in fetal bone marrow biopsies using a new adaptation of the Feulgen technique to measure DNA content and estimate megakaryocyte ploidy from biopsy specimens. Pediatr Res. 1996;39:166-170. (Pubitemid 26003539)
2. Hegyi E, Nakazawa M, Debili N, et al. Developmental changes in human megakaryocyte ploidy. Exp Hematol. 1991;19:87-94.
3. Levin SD, Koelling RM, Friend SL, et al. Thymic stromal lymphopoietin: a cytokine that promotes the development of IgM+ B cells in vitro and signals via a novel mechanism. J Immunol. 1999;162:677-683. (Pubitemid 29035386)
4. Olson TA, Levine RF, Mazur EM, et al. Megakaryocytes and megakaryocyte progenitors in human cord blood. Am J Pediatr Hematol Oncol. 1992;14:241-247.
5. Sola-Visner MC, Christensen RD, Hutson AD, et al. Megakaryocyte size and concentration in the bone marrow of thrombocytopenic and nonthrombocytopenic neonates. Pediatr Res. 2007;61:479-484. (Pubitemid 46569304)
6. Harker LA. Kinetics of thrombopoiesis. J Clin Invest. 1968;47:458-465.
7. Tomer A, Friese P, Conklin R, et al. Flow cytometric analysis of megakaryocytes from patients with abnormal platelet counts. Blood. 1989;74:594-601. (Pubitemid 19208798)
8. Allen Graeve JL, de Alarcon PA. Megakaryocytopoiesis in the human fetus. Arch Dis Child. 1989;64:481-484.
9. Ma DC, Sun YH, Chang KZ, et al. Developmental change of megakaryocyte maturation and DNA ploidy in human fetus. Eur J Haematol. 1996;57:121-127. (Pubitemid 26313363)
10. Liu ZJ, Italiano J Jr, Ferrer-Marin F, et al. Developmental differences in megakaryocytopoiesis are associated with up-regulated TPO signaling through mTOR and elevated GATA-1 levels in neonatal megakaryocytes. Blood. 2011;117:4106-4117.
11. Castle V, Andrew M, Kelton J, et al. Frequency and mechanism of neonatal thrombocytopenia. J Pediatr. 1986;108:749-755. (Pubitemid 16064127)
12. Mattia G, Vulcano F, Milazzo L, et al. Different ploidy levels of megakaryocytes generated from peripheral or cord blood CD34+ cells are correlated with different levels of platelet release. Blood. 2002;99:888-897. (Pubitemid 34525550)
13. Dolan MM, Singleton TP, Neglia J, et al. Aplastic anemia and monosomy 7-associated dysmegakaryocytopoiesis. Am J Clin Pathol. 2006;126:925-930. (Pubitemid 44901846)
14. Brunning RD, Porwit A, Orazi A, et al. Myelodysplastic syndromes/neoplasms, overview. In: Swerdlow SH, Campo E, Harris NL, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2008:88-93.
15. Foucar K. Myelodysplastic syndromes. In: Foucar K, Reichard K, Czuchlewski D, eds. Bone Marrow Pathology. Chicago, IL: 3rd ed. ASCP Press; 2010:331-359:
16. Perkins S. Myeloproliferative and myelodysplastic disorders. In: Collins RD, Swerdlow SH, eds. Pediatric Hematopathology. Philadelphia, PA: Churchill Livingstone; 2001:147-155.
17. Hasserjian RP, Le Beau MM, List AF, et al. Myelodysplastic syndromes/myelodysplastic syndrome with isolated del(5q). In: Swerdlow SH, Campo E, Harris NL, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2008:102-103.
18. Vardiman JW, Melo JV, Baccarani M, et al. Myeloproliferative neoplasms/chronic myelogenous leukaemia, BCR-ABL1 positive. In: Swerdlow SH, Campo E, Harris NL, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2008:32-37.
19. Baumann I, Niemeyer CM, Brunning RD, et al. Acute myeloid leukaemia and related precursor neoplasms/myeloid proliferations related to Down syndrome. In: Swerdlow SH, Campo E, Harris NL, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: International Agency for Research on Cancer; 2008:142-144.